Early breast cancer.
Breast cancer remains a common disease throughout the world. Here we review new knowledge about early breast cancer obtained during the past 5 years. The prognosis of early breast cancer is generally favorable. Especially, ductal carcinoma in situ has been regarded as a non-life-threatening disease. Therefore, early diagnosis and early onset of the treatment has been important. Early age at menarche, late age at first birth, and late age at menopause are related to breast cancer risk. Examination by mammography and ultrasonography is still the most effective means of detection for premenopausal and postmenopausal women, respectively. Additionally, there have been important advances in MRI, sentinel lymph node biopsy, breast-conserving surgery, partial breast irradiation, neoadjuvant systemic therapy, and adjuvant systemic therapy. Another approach to keeping the disease under control is the elucidation of breast cancer's molecular biological features. Assessment of potential molecular targets can lead to early diagnosis and molecular targeted treatment.
Suzuki
Tomoyoshi
T
Department of Surgery, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkomagome, Tokyo 113-0025, Japan.
Toi
Masakazu
M
Saji
Shigehira
S
Horiguchi
Kazumi
K
Aruga
Tomoyuki
T
Suzuki
Eiji
E
Horiguchi
Shinichiro
S
Funata
Nobuaki
N
Karasawa
Katsuyuki
K
Kamata
Noriko
N
D001943:Breast Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007564:Japan